|
1
|
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
|
Lancet
|
2005
|
3.75
|
|
2
|
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group.
|
J Clin Oncol
|
1999
|
2.25
|
|
3
|
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party.
|
J Natl Cancer Inst
|
1999
|
2.15
|
|
4
|
Randomised consent designs in cancer clinical trials.
|
Eur J Cancer
|
1995
|
2.07
|
|
5
|
A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
|
Br J Cancer
|
1991
|
1.93
|
|
6
|
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
|
Ann Oncol
|
2002
|
1.87
|
|
7
|
Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment.
|
Clin Oncol (R Coll Radiol)
|
2006
|
1.74
|
|
8
|
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.
|
J Clin Oncol
|
1992
|
1.73
|
|
9
|
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study.
|
Lancet
|
2002
|
1.68
|
|
10
|
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.
|
J Clin Oncol
|
1992
|
1.67
|
|
11
|
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.
|
Eur J Cancer
|
1997
|
1.55
|
|
12
|
Thirty years of Medical Research Council randomized trials in solid tumours.
|
Clin Oncol (R Coll Radiol)
|
1997
|
1.38
|
|
13
|
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|
J Clin Oncol
|
1997
|
1.33
|
|
14
|
Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research Council.
|
Clin Oncol (R Coll Radiol)
|
1997
|
1.24
|
|
15
|
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.
|
J Clin Oncol
|
1996
|
1.18
|
|
16
|
A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
|
Cancer
|
2000
|
1.16
|
|
17
|
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
|
J Clin Oncol
|
1996
|
1.14
|
|
18
|
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
|
Br J Cancer
|
2004
|
1.12
|
|
19
|
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.
|
Br J Cancer
|
1987
|
1.10
|
|
20
|
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.
|
Eur J Cancer
|
1997
|
1.09
|
|
21
|
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
|
Br J Cancer
|
2000
|
1.08
|
|
22
|
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
|
Br J Cancer
|
2005
|
1.06
|
|
23
|
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
|
Br J Cancer
|
1999
|
1.06
|
|
24
|
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group.
|
J Urol
|
1998
|
1.04
|
|
25
|
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.
|
Ann Oncol
|
2012
|
1.01
|
|
26
|
The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.99
|
|
27
|
External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients.
|
Br J Cancer
|
2003
|
0.89
|
|
28
|
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).
|
Br J Cancer
|
2005
|
0.83
|
|
29
|
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).
|
Ann Oncol
|
2009
|
0.80
|
|
30
|
Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
|
Br J Surg
|
2003
|
0.80
|
|
31
|
A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party.
|
Int J Radiat Oncol Biol Phys
|
1989
|
0.79
|
|
32
|
Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls.
|
Radiother Oncol
|
2003
|
0.79
|
|
33
|
Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report.
|
Eur Urol
|
1993
|
0.79
|
|
34
|
UK management practices in stage I seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis managed with surveillance.
|
Clin Oncol (R Coll Radiol)
|
2011
|
0.78
|
|
35
|
Use of strategies to improve retention in primary care randomised trials: a qualitative study with in-depth interviews.
|
BMJ Open
|
2014
|
0.78
|
|
36
|
Identifying subgroups among poor prognosis patients with nonseminomatous germ cell cancer by tree modelling: a validation study.
|
Ann Oncol
|
2004
|
0.77
|
|
37
|
A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.
|
Clin Oncol (R Coll Radiol)
|
1997
|
0.76
|
|
38
|
Response of 145 spontaneous canine head and neck tumours to radiation versus radiation plus microwave hyperthermia: results of a randomized phase III clinical study.
|
Int J Hyperthermia
|
1995
|
0.75
|
|
39
|
Primary chemotherapy after orchidectomy for stage I and II nonseminoma.
|
Semin Oncol
|
1998
|
0.75
|
|
40
|
Prognostic factors in metastatic non-seminomatous germ cell tumours: the Medical Research Council studies.
|
Eur Urol
|
1993
|
0.75
|